718 Results

Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) - short version

In 2010, under the guidance of the DGAI (German Society of Anaesthesiology and Intensive Care Medicine) and DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine), twelve German medical societies published...

Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit

To revise the "Clinical Practice Guidelines for the Sustained Use of Sedatives and Analgesics in the Critically Ill Adult" published in Critical Care Medicine in 2002.

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

Allergic rhinitis represents a global health problem affecting 10% to 20% of the population.

Adalimumab for the treatment of adults with psoriasis

The severity of a person's psoriasis before and during treatment should be assessed by considering the redness, thickness and scaliness of the plaques, the area of the body involved, and how the condition...

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

Psoriasis is a common, chronic inflammatory skin disease which typically follows a relapsing and remitting course, and is associated with joint disease in approximately 25% of patients.

Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis

To provide the dermatologist a guide focuses specifically on the diagnosis and management of the diseases most often found in patients with psoriasis.

Psoriasis Clinical Knowledge Summaries - UK

A readily accessible summary for PCPs of the current evidence base and practical guidance on best practice in a number of psoriasis scenarios, from the UK's National Institute for Health and Care Excellence (NICE).

Psoriasis overview NICE Pathways

This document contains a single pathway diagram and uses numbering to link the boxes to the associated recommendations.

Adalimumab for treating moderate to severe hidradenitis suppurativa

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

Guidelines of care for the management of psoriasis and psoriatic arthritis

Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.

Load more